van Leeuwen FWB - Search Results

1

Chemically augmented malaria sporozoites display an altered immunogenic profile.

Duszenko N, van Schuijlenburg R, Chevalley-Maurel S, van Willigen DM, de Bes-Roeleveld L, van der Wees S, Naar C, Baalbergen E, Heieis G, Bunschoten A, Velders AH, Franke-Fayard B, van Leeuwen FWB, Roestenberg M. Duszenko N, et al. Among authors: van leeuwen fwb, van der wees s, van schuijlenburg r, van willigen dm. Front Immunol. 2023 Aug 31;14:1204606. doi: 10.3389/fimmu.2023.1204606. eCollection 2023. Front Immunol. 2023. PMID: 37720224 Free PMC article.

2

Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label.

Kuil J, Velders AH, van Leeuwen FW. Kuil J, et al. Bioconjug Chem. 2010 Oct 20;21(10):1709-19. doi: 10.1021/bc100276j. Bioconjug Chem. 2010. PMID: 20812730 Review.

3

Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.

Bunschoten A, Buckle T, Visser NL, Kuil J, Yuan H, Josephson L, Vahrmeijer AL, van Leeuwen FW. Bunschoten A, et al. Chembiochem. 2012 May 7;13(7):1039-45. doi: 10.1002/cbic.201200034. Epub 2012 Apr 13. Chembiochem. 2012. PMID: 22505018 Free PMC article.

4

Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist.

Buckle T, van Berg NS, Kuil J, Bunschoten A, Oldenburg J, Borowsky AD, Wesseling J, Masada R, Oishi S, Fujii N, van Leeuwen FW. Buckle T, et al. Am J Nucl Med Mol Imaging. 2012;2(1):99-109. Epub 2011 Dec 15. Am J Nucl Med Mol Imaging. 2012. PMID: 23133805 Free PMC article.

5

Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS.

Buckle T, Kuil J, van den Berg NS, Bunschoten A, Lamb HJ, Yuan H, Josephson L, Jonkers J, Borowsky AD, van Leeuwen FW. Buckle T, et al. PLoS One. 2013;8(1):e48324. doi: 10.1371/journal.pone.0048324. Epub 2013 Jan 11. PLoS One. 2013. PMID: 23326303 Free PMC article.

6

Development and prospects of dedicated tracers for the molecular imaging of bacterial infections.

Bunschoten A, Welling MM, Termaat MF, Sathekge M, van Leeuwen FW. Bunschoten A, et al. Bioconjug Chem. 2013 Dec 18;24(12):1971-89. doi: 10.1021/bc4003037. Epub 2013 Nov 20. Bioconjug Chem. 2013. PMID: 24200346 Review.

7

An activatable, polarity dependent, dual-luminescent imaging agent with a long luminescence lifetime.

Rood MT, Oikonomou M, Buckle T, Raspe M, Urano Y, Jalink K, Velders AH, van Leeuwen FW. Rood MT, et al. Chem Commun (Camb). 2014 Sep 4;50(68):9733-6. doi: 10.1039/c4cc04015e. Chem Commun (Camb). 2014. PMID: 25019263

8

U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform.

van Oosterom MN, Kreuger R, Buckle T, Mahn WA, Bunschoten A, Josephson L, van Leeuwen FW, Beekman FJ. van Oosterom MN, et al. EJNMMI Res. 2014 Oct 11;4:56. doi: 10.1186/s13550-014-0056-0. eCollection 2014. EJNMMI Res. 2014. PMID: 25386389 Free PMC article.

9

uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.

Boonstra MC, van Driel PB, van Willigen DM, Stammes MA, Prevoo HA, Tummers QR, Mazar AP, Beekman FJ, Kuppen PJ, van de Velde CJ, Löwik CW, Frangioni JV, van Leeuwen FW, Sier CF, Vahrmeijer AL. Boonstra MC, et al. Oncotarget. 2015 Jun 10;6(16):14260-73. doi: 10.18632/oncotarget.3680. Oncotarget. 2015. PMID: 25895028 Free PMC article.

10

MMP-2/9-Specific Activatable Lifetime Imaging Agent.

Rood MT, Raspe M, ten Hove JB, Jalink K, Velders AH, van Leeuwen FW. Rood MT, et al. Sensors (Basel). 2015 May 12;15(5):11076-91. doi: 10.3390/s150511076. Sensors (Basel). 2015. PMID: 25985157 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page